Filing metadata

Accession number
0001562180-23-002583
Form type
Form 3
Filer
Edgewise Therapeutics, Inc.
CIK
CIK 1710072
Filed
Mar 07, 2023
Reporting period
Mar 02, 2023
Description
Initial ownership

Explore SEC Filings Hub